| Literature DB >> 35005445 |
Ward Shalash1, Sonia R Ahrens1, Liudmila A Bardonova1,2, Vadim A Byvaltsev2,3, Morgan B Giers1.
Abstract
INTRODUCTION: In this study, magnetic resonance imaging data was used to (1) model IVD-specific gradients of glucose, oxygen, lactate, and pH; and (2) investigate possible effects of covariate factors (i.e., disc geometry, and mean apparent diffusion coefficient values) on the IVD's microenvironment. Mathematical modeling of the patient's specific IVD microenvironment could be important when selecting patients for stem cell therapy due to the increased nutrient demand created by that treatment.Entities:
Keywords: finite element modeling; intervertebral disc; mass transport; mathematical model; metabolism; nutrient; regeneration
Year: 2021 PMID: 35005445 PMCID: PMC8717112 DOI: 10.1002/jsp2.1179
Source DB: PubMed Journal: JOR Spine ISSN: 2572-1143
Summary of patient characteristics
| Patient characteristic | Grade 2 (n = 10) | Grade 3 (n = 10) | Grade 4 (n = 10) | Grade 5 (n = 7) |
|
|---|---|---|---|---|---|
| Age | 36.5 ± 7.0 | 36.6 ± 6.6 | 37.4 ± 7.5 | 48.4 ± 6.8 | 0.0014 |
| BMI | 142.2 ± 51 | 101.5 ± 37 | 92.8 ± 17 | 103 ± 29 | 0.4770 |
| Height (cm) | 116.8 ± 49 | 152 ± 47 | 175 ± 6.4 | 163 ± 45 | 0.2534 |
| Sex (m:f) | 9:1 | 9:1 | 10:0 | 7:0 | 0.6442 |
| Disc pathology |
|
|
|
| 1.82E−06 |
| None | 90.0% | 80.0% | 20.0% | 0.0% |
|
| Herniation | 0.0% | 20.0% | 70.0% | 57.1% |
|
| Spondylosis | 0.0% | 0.0% | 10.0% | 28.6% |
|
| Stenosis | 10.0% | 0.0% | 0.0% | 14.3% | |
| Disc level |
|
|
|
| 0.0241 |
| L3L4 | 70.0% | 30.0% | 10.0% | 0.0% |
|
| L4L5 | 10.0% | 60.0% | 40.0% | 28.6% |
|
| L5S1 | 20.0% | 10.0% | 50.0% | 71.4% |
|
Note: Ten IVDs from each degeneration grade were randomly chosen from the 21 patients. Randomization could not be applied for grade 5 because only 7 IVDs were available. IVDs included in this study represent levels between L3L4 and L5S1 due to image artifacts that distorted higher levels, that is, L1L2 and L2L3. The table also consists of each patient's age and IVD pathology condition. ^P‐values reported are from one‐way ANOVA or Kruskal‐Wallis when data were parametric or nonparametric, respectively.
FIGURE 1Annulus fibrosus (AF), cartilaginous endplates (CEP), and nucleus pulposus (NP) masks (in white left to right) were segmented in Materialize Mimics 21.0 for each patient. AF, CEP, and NP masks from intervertebral disc #1 L3L4 were segmented then overlaid over a T2w scan in this figure
FIGURE 2Diffusion weighted‐imaging (left) for intervertebral disc #1, level L3L4, unprocessed apparent diffusion coefficient (ADC) map (middle), cropped ADC map (right)
FIGURE 3Adaptive mesh refinement for intervertebral disc #1, level L3L4. COMSOL Multiphysics had automatically inserted additional mesh elements to minimize error, increase accuracy. and decrease computational time (left). Zoomed view of mesh boundary layers (right) shows the areas around the IVD boundaries that contained additional smaller mesh elements
FIGURE 4Glucose diffusion map of intervertebral disc #1, disc level L3L4. Incorporating apparent diffusion coefficient (ADC) maps to calculate diffusion in the nucleus pulposus reflected the local variation in diffusion coefficients. No gradient could be observed in the cartilaginous endplates and annulus fibrosus because ADC maps were not obtained at a resolution high enough to allow for extraction of diffusion coefficients
The model's constant parameters
| IVD region | Water content (%) | Diffusion coefficient (m2/s) | Cell density (1/m3) | |||
|---|---|---|---|---|---|---|
| — | Healthy disc | Degenerate disc | Glucose | Oxygen | Lactate | — |
| NP | 83[ | 78[ | see “Section | 4.0E+12[ | ||
| AF | 69[ | 53[ | 2.85E−10[ | 1.1E−9[ | 4.24E−10[ | 9.0E+12[ |
| CEP | 60[ | 42[ | 2.11E−10[ | 7.81E−10[ | 3.14E−10[ | 1.5E+13[ |
Note: IVD parameters for water content, diffusion coefficients for glucose, oxygen, and lactate, and cell density were taken from other published models. These parameters were multiplied with each mask to create an IVD map of varying parameter values based on each anatomical part.
Average values of inner and outer AF.
Comparison of this model's diffusion coefficients and literature values
| Year | Author | Model | IVD region |
|
|
|
|---|---|---|---|---|---|---|
| This model | CEP | 6.73E−11 | 1.50E−10 | 7.96E−10 | ||
| AF | 9.08E−11 | 2.02E−10 | 1.07E−09 | |||
| NP | 1.22E−10 to 2.54E−10 | 1.83E−10 to 3.81E−10 | 3.90E−10 to 8.13E−10 | |||
| 2016[ | Cisewski | FE model | CEP | 2.68E−11 | 4.52E−11 | — |
| 2016[ | Wu | Human ex vivo | CEP | 2.68E−11 | 4.52E−11 | — |
| 2012[ | Jackson | Human in vitro | AF | 3.56E−11 to 8.71E−11 | — | 1.13E−10 to 1.85E−9 |
| 2009[ | Jackson | Bovine in vitro | AF | — | — | 1.56E−09 |
| 2008[ | Jackson | Bovine in vitro | AF | 1.38E−10 to 9.17E−11 | — | — |
| 2009[ | Magnier | FE model | CEP | 9.17E−10 | 1.39E−09 | 3.00E−09 |
| 2007[ | Soukane | FE model | CEP | 2.11E−10 | 3.14E−10 | 7.81E−10 |
| AF | 2.85E−10 | 4.24E−10 | 1.05E−09 | |||
| NP | 3.78E−10 | 5.61E−10 | 1.39E−09 | |||
| 1975[ | Maroudas | Human in vitro | CEP | 2.43E−10 | — | — |
| AF | 2.50E−10 | — | — | |||
| 2003[ | Sélard | FE model | AF | 2.50E−10 | 4.86E−10 | 8.33E−10 |
| NP | 3.75E−10 | 6.11E−10 | 1.28E−09 | |||
Note: Diffusion coefficients of glucose, oxygen, and lactate used in this model were compared with their corresponding values reported in the literature. This model's coefficients, which were extracted from ADC maps and multiplied by scaling factors, fell within the range of diffusion coefficients reported in the literature. The range of diffusion coefficients used in the NP for this model depicted the highest and lowest values obtained from the ADC maps.
Examples of solute and pH distribution models of discs with different degeneration grades
| Patient | Grade level | T2w | ADC | Glucose gradient (mM) | Lactate gradient (mM) | Oxygen gradient (kPa) |
|---|---|---|---|---|---|---|
| 1 | 2 |
|
|
|
|
|
| 4 | 3 |
|
|
|
|
|
| 19 | 4 |
|
|
|
|
|
| 10 | 5 |
|
|
|
|
|
Note: All discs were presented with the posterior aspect on the left and the anterior side on the right. Each model was constructed in COMSOL Multiphysics 5.4 using the middle sagittal slice of each patient's T2w, T1w, and DWI scans. pH distributions (linearly correlated to lactate levels) were not shown. The lowest levels of nutrients and the highest acidity levels appeared at the inner AF region in most discs (refer to Table S1 for complete model results).
FIGURE 5Estimation of concentration averages with SD in intervertebral discs (IVDs) of Pfirrmann grades 2–5. Average solute concentrations were calculated using COMSOL Multiphysics for (A1) glucose (mM), (B1) lactate (mM), (C1) oxygen (kPa). COMSOL Multiphysics identified critical solute values in the inner AF for (A2) minimum glucose (B2), maximum lactate (C2) minimum oxygen (* = 0.05, § = 0.005, # = 0.0001). Patients #5, 7, and 18 were outliers. Patients #14 and 20 have larger and small IVD areas, respectively (Figure 7)
FIGURE 7Average intervertebral disc area in pixels for each degeneration group. Outliers are marked with the corresponding patient number. An * indicated significance with a P‐value of .05. Patients #14, 18, and 20 were outliers
Quantified changes in solute concentrations between different degeneration grades
| Degeneration progression | Glucose | Lactate | Oxygen |
|---|---|---|---|
| Grade 2—Grade 3 | −2.79% | 4.84% | −0.91% |
| Grade 3—Grade 4 | −2.54% | 7.59% | −1.53% |
| Grade 4—Grade 5 | 1.55% | −3.81% | 1.10% |
Note: COMSOL Multiphysics 5.4 automatically identified minimum and maximum solute values in the IVD. However, all points fell within the inner AF (except for the following patients: #13, #15, and #18 in grade 4; and patient #20 in grade 5). (n = 10 for grades 2, 3, 4 and n = 7 for grade 5).
FIGURE 6Estimation of solute concentration means for glucose (mM), oxygen (kPa), and lactate (mM) in the IVD vs patient characteristics. (A1, A2) disc level, (B1, B2) IVD pathology condition, and (C1, C2) patient sex. An * indicated significance with a P‐value of .05
Partial correlations for different measured metrics in the disc
| Variable | Min. glucose | Max. lactate | Min. oxygen | Ave. glucose | Ave. lactate | Ave. oxygen | Area | Height | Mean ADC intensity |
|---|---|---|---|---|---|---|---|---|---|
| Min. glucose | 1.000 | −1.000 | 0.997 | 0.789 | −0.868 | 0.866 | −0.602 | −0.400 | 0.562 |
| Max. lactate | −1.000 | 1.000 | −0.997 | −0.788 | 0.866 | −0.864 | 0.604 | 0.407 | −0.574 |
| Min. oxygen | 0.997 | −0.997 | 1.000 | 0.769 | −0.848 | 0.849 | −0.608 | −0.413 | 0.574 |
| Ave. glucose | 0.789 | −0.788 | 0.769 | 1.000 | −0.976 | 0.972 | −0.670 | −0.611 | 0.298 |
| Ave. lactate | −0.868 | 0.866 | −0.848 | −0.976 | 1.000 | −0.996 | 0.709 | 0.544 | 0.495 |
| Ave. oxygen | 0.866 | −0.864 | 0.849 | 0.972 | −0.996 | 1.000 | −0.743 | −0.607 | −0.469 |
Note: Reported numbers are Pearson R correlation values of fitted linear regression between groups. The sign indicates a positive or negative correlation. All correlations were considered significant with P <.05. Grey highlighting indicates p<0.05.
FIGURE 8Sensitivity analysis on model variables including, diffusivity of the annulus fibrosus, cartilaginous endplates, and nucleus pulposus, reaction rates (RXN) of glucose, lactate, and oxygen, cell density, and disc size. Solute % change from baseline values are presented for (A) glucose, (B) lactate, and (C) oxygen. General linear model was performed to find significance indicated by * (P = .05)
FIGURE 9Streamlines show lactate flux through the different parts of the IVD (annulus fibrosus [AF]: light gray, cartilaginous endplates [CEP]: dark gray, nucleus pulposus [NP]: white). The color scale reflects flux magnitude of lactate. High flux was observed near both CEPs, while the AF experienced low flux indicating better transport through the former. Long diffusion pathways extending from the inner AF through the CEP lead to low nutrient levels in the inner AF
FIGURE 10Comparison of increasing the nucleus pulposus cell density on glucose distribution (mM) in patient # 2, grade 3. Cell density of 4000 cells/mm3 was used as a baseline value. 6000 cells/mm3 represents a 150% increase. While 11 000 cells/mm3 was the highest dose reported to be used by clinical trials ,
Summary of current vs expected variations in solute transport parameters
| Parameter | Current model specificity | Expected variation between patients |
|---|---|---|
| IVD Morphology | Patient specific | Expected to vary based on patient height, biochemical composition, gross defects, degeneration, mechanical loading, and level |
| AF solute diffusion coefficients | Pfirrmann specific | Expected to vary based on biochemical composition, location, mechanical loading, and gross defects |
| CEP solute diffusion coefficients | Pfirrmann specific | Expected to vary based on biochemical composition, location, mechanical loading, and gross defects |
| NP solute diffusion coefficients | Patient specific | Expected to vary based on biochemical composition, location and gross defects |
| AF solute boundary conditions | Uniform | Expected to vary based on capillary density, and solute perfusion |
| CEP solute boundary conditions | Uniform | Expected to vary based on thickness of the boney endplate, capillary density, number of marrow cavities and gross abnormalities |
| Solute initial condition | Uniform | Expected to vary based on IVD physiological conditions |
| AF diffusivity | Pfirrmann specific | Expected to vary based on spinal morphology, biochemical composition, location, mechanical loading, and pathophysiology |
| CEP diffusivity | Pfirrmann specific | Expected to vary based on spinal morphology, location, and endplate pathophysiology, including capillary density, lesions, and calcification |
| NP diffusivity | Pfirrmann specific | Expected to vary based on spinal morphology, location, biochemical composition, and pathophysiology |
| AF cell density | Uniform | Expected to vary based on glucose and oxygen availability, acidity, location, and patient age |
| CEP cell density | Uniform | Expected to vary based on glucose and oxygen availability, acidity, location, and patient age |
| NP cell density | Uniform | Expected to vary based on glucose and oxygen availability, acidity, location, and patient age |
| Cell metabolism | Based on glucose/oxygen concentrations | Expected to vary more widely based on signaling factors, senescence, and patient age |
| Water content | Pfirrmann specific | Expected to vary based on biochemical composition, location, mechanical loading, and pathophysiology |
Note: The specificity of each model parameter is given as well as the expected source of variation for each parameter. Patient specific factors are highlighted in gray.
Literature values of water content and cell density showing various values reported and used for IVD modeling
| Water content (%) | Cell density × 103 (1/mm3) | |||||||
|---|---|---|---|---|---|---|---|---|
| Year | Author | Model | CEP | AF | NP | CEP | AF | NP |
| 2016 | Zhu[ | 3D model | — | 70‐85 | 85 | — | 9 | 4 |
| 2010 | A. Shirazi[ | 3D model | 60 | 66–73 | 80 | 15 | 4–16 | 4 |
| 2007 | Iatridis[ | — | 66 | 86 | — | — | — | |
| 2005 | Soukane[ | 3D model | — | — | 85 | — | 9 | 4 |
| 1998 | Bartels[ | Human in‐vivo | — | — | — | 15 | 9 | 4 |
| 1988 | Urban[ | Human in‐vitro | — | — | 75‐85 | — | — | — |
| 1985 | Kraemer[ | Human in‐vivo | — | 73‐80 | 76‐90 | — | — | — |
The high value for the inner AF and the low value for the outer AF.
A high value for healthy young individuals, while the low value for older individuals.